通过调节STAT3/FAK信号轴来抑制瘤发生和转移
Fan Nie1, Haojing Jiang1, Ruyu Cao1
1State Key Laboratory of Medicinal Chemistry Biology, College of Pharmacy, and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300350, People's Republic of China.
European journal of pharmacology
|August 30, 2025
概括
一种天然化合物8-epi-helenalin对肝细胞癌 (HCC) 具有强烈的抗癌作用. 它通过向多个途径来抑制瘤生长,迁移和血管生成.
科学领域:
- 自然产品化学
- 癌症学
- 药理学
背景情况:
- 肝细胞癌 (HCC) 是全球的主要健康问题.
- 自然产品是抗癌新药的重要来源.
研究的目的:
- 为了隔离和表征8-epi-helenalin从日本.
- 评估8-epi-helenalin对HCC的体外和体内抗癌潜力.
- 阐明其抗瘤作用的分子机制.
主要方法:
- 从日本中分离出8-epi-helenalin.
- 使用人类HCC细胞系 (HepG2) 的体外抗繁殖试验.
- 使用斑马鱼异种移植模型进行体内疗效评估.
- 涉及细胞亡,细胞迁移,铁亡和血管生成途径的机制研究.
主要成果:
- 8 - 乙烯显示出对HCC细胞的强烈抗增殖作用.
- 在体内研究证实了瘤生长和转移抑制.
- 这些机制包括诱导亡 (STAT3通路),抑制迁移 (FAK通路),触发铁亡 (脂质ROS,GSH) 和抑制血管生成.
结论:
- 8 - 烯对HCC具有多重向的抗癌活性.
- 它有效地通过多种分子途径抑制HCC的进展.
- 作为HCC治疗的治疗候选物,8-epi-helenalin具有显著的前景.
相关概念视频
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K


